title: Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma.
authors.affiliation: Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
authors.forename: Marta
authors.initials: M
authors.lastname: Celegato
authors.affiliation: Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
authors.forename: Cinzia
authors.initials: C
authors.lastname: Borghese
authors.affiliation: Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
authors.forename: Naike
authors.initials: N
authors.lastname: Casagrande
authors.affiliation: Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Mongiat
authors.affiliation: Department of Pathology and Medical Biology, University of Groningen, Groningen, The Netherlands.
authors.forename: Xaver U
authors.initials: XU
authors.lastname: Kahle
authors.affiliation: Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
authors.forename: Alice
authors.initials: A
authors.lastname: Paulitti
authors.affiliation: Division of Medical Oncology A, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Spina
authors.affiliation: Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
authors.forename: Alfonso
authors.initials: A
authors.lastname: Colombatti
authors.affiliation: Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
authors.forename: Donatella
authors.initials: D
authors.lastname: Aldinucci
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D001310:Auranofin / Q000627:therapeutic use*; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm; D004354:Drug Screening Assays, Antitumor; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D023041:Xenograft Model Antitumor Assays
chemical_list: D000970:Antineoplastic Agents; D001310:Auranofin